Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Disease Study of the Efficacy and Safety of Pasireotide s.c. +/- Cabergoline in Patients With Cushing's Dise ...
A Phase II Trial to Assess the Efficacy and Safety of Pasireotide s.c. Alone or in Combination With Cabergoline in Patients With Cushing's Disease A Phase II Trial to Assess the Efficacy and Safety of Pasireotide s.c. Alone or in Combination With ...
Cushings Disease
Drug: Pasireotide with or without cabergoline
Novartis Pharmaceuticals
NULL
Terminated
18 Years
N/A
All
68
Phase 2
United States;Argentina;Belgium;Brazil;Colombia;France;Germany;Greece;Hungary;India;Italy;Malaysia;Mexico;Netherlands;Spain;Turkey;Australia;Bulgaria;Venezuela United States;Argentina;Belgium;Brazil;Colombia;France;Germany;Greece;Hungary;India;Italy;Malaysia;M ...